Benjamin Frempah

Benjamin Frempah has extensive experience in business development and competitive intelligence within the life sciences sector. Serving as Director and Associate Director of Business Development at Omega Therapeutics from April 2022 to January 2024, Benjamin previously contributed as Senior Manager of Competitive Intelligence at Amunix Pharmaceuticals, where significant strategic insights were developed to support fundraising and business development initiatives. Prior consulting experience at ClearView Healthcare Partners involved providing strategic guidance to life sciences companies. Benjamin holds a Ph.D. in Pharmaceutical Sciences from the University of Oklahoma Health Sciences Center, where research focused on the IL-6/IL-6R alpha function in skin inflammation and breast cancer. Additionally, participation in the Bridge to BCG program highlights a commitment to bridging academic and consulting practices.